Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis. Gholipour T, Ghazizadeh T, Babapour S, Mansouri B, Ghafarpour M, Siroos B, Harirchian M H Iran J Allergy Asthma Immunol. 2015 Feb; 14(1):91-7. PMID: 25530144. Abstract CommentRecommendBookmarkWatch